Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Women We Admire Announces Top 50 Women Leaders in Medicine of 2022


Women We Admire is pleased to announce the Top 50 Women Leaders in Medicine of 2022. This group of individuals is comprised of physicians, doctors, clinicians and educators who are changing the face of medicine through their profession, teachings, and personal lives. We recognize and honor each awardee for their commitment to quality care and advancements within the field. Their initiatives and dedication have proven to be invaluable contributions to society, both locally and internationally.

Among this year’s awardees is Avril Beckford, Chief Pediatric Officer of WellStar Health System, whose passion in early childhood brain development and emotional intelligence has led her to be published in textbooks and within articles in medical journals and parenting & teaching publications. Awardee Mariam Bekhit, Chief Medical Officer of Hidden River Eating Disorder Treatment, is a passionate psychiatrist who treats patients with a combined psychotherapeutic and pharmacological intervention approach. Also awarded is Theresa Heah, Chief Medical Officer and President of Kriya Therapeutics, who is advancing the company’s ophthalmology gene therapies and overall portfolio through its in-house R&D and business development engines.

Please join us in recognizing the outstanding accomplishments of the Top 50 Women Leaders in Medicine of 2022.

Este Geraghty (Esri), Avril Beckford (WellStar Health System), Natalie Hartenbaum (OccuMedix), Mariam Bekhit (Hidden River Eating Disorder Treatment), Suzanna Fox (Atrium Health), Alice Lorch (Massachusetts Eye and Ear), Theresa Heah (Kriya Therapeutics), Stephanie Coyne (Veterans Administration), Jess Guarnaschelli (Medpace), Meera Wells (Hackensack Meridian Health), Aenor Sawyer (University of California; Skeletal Health Service UCSF Department Orthopaedic Surgery), Arshiya Seth (Cambridge Health Alliance), Arti Lakhani (AMITA Health), Theresa Pazionis (Temple Health – Temple University Health System), Sulin Chung (Envision Healthcare), Luxme Hariharan (Nicklaus Children’s Health System), Shanna Newbold (Vituity), Jamie Engel (Parkview Medical Center), Elana Oberstein (ModMed), Ilkcan Cokgor (MarinHealth), Annie Varughese (North Houston Family Medicine), Allyson Shrikhande (Pelvic Rehabilitation Medicine), Aarti Singla (Beacon Orthopaedics & Sports Medicine), Rohini Bogineni (Doctors Medical Center of Modesto), Melissa Rosenhan (Schweiger Dermatology Group), and many others.

To view the full list, visit https://thewomenweadmire.com/2022/11/07/top-50-women-leaders-in-medicine-of-2022/

About Women We Admire

Women We Admire provides news and information on today’s women leaders in business, entertainment, sports, motherhood, medicine, law, and many other fields. We cover a broad range of topics and areas of interest aimed at recognizing the achievements of exceptional women while inspiring others to aim high and continue their journey towards reaching their full potential. Women We Admire and its affiliates circulate its content to over 32,000 individuals and businesses.

Share article on social media or email:

AWKO Files Class Action Lawsuit Regarding Alleged Cancerous Hair Relaxing/Straightening Products


This is a pivotal moment for all of the women who trusted these companies and used their hair relaxers year after year based on the belief that they were safe to use.

On November 3, 2022, Aylstock, Witkin, Kreis & Overholtz, PLLC (“AWKO”) filed the first class action lawsuit against L’Oréal USA, Inc. and Softsheen-Carson, Inc. for alleged toxic and dangerous hair relaxers and/or straighteners that are directly marketed to women of color. These products contain hazardous endocrine disrupting chemicals and other toxins that are known to contribute to and/or cause devastating and irreversible injuries.

AWKO filed this class action lawsuit in response to recent studies finding that Black women who use hair relaxing products develop cancers, like uterine cancer, at a disproportionate rate as compared to White women. This is very troubling, as the corporations marketing these products specifically target Black women, as well as Black children, many of whom begin using these products at a young age. This lawsuit centers on consumer claims and a need for medical monitoring of all women who have used these products, particularly as the science underlying its horrible injuries develops and is examined more thoroughly.

Hannah Pfeifler, an associate at AWKO, stated: “This is a pivotal moment for all of the women who trusted these companies and used their hair relaxers year after year based on the belief that they were safe to use.”

For over 20 years, AWKO has been fighting for the rights of women who have suffered devastating, life-altering injuries from defective products and/or dangerous pharmaceutical drugs and medical devices, such as hormone replacement therapy drugs, talcum powder, and transvaginal mesh. AWKO is honored to continue fighting for women in this litigation.

United States District Court Northern District of Illinois Eastern Division

Case Number: 1:22-cv-06110

Share article on social media or email:

CDC Awards Funding for Mount Sinai World Trade Center (WTC) Health Program Clinical Center of Excellence


The ongoing support of the federal government ensures that we’re able to provide critically needed services to responders,” said Michael Crane, MD, MPH, Medical Director of the Selikoff Centers.

The National Institute for Occupational Safety and Health, part of the Centers for Disease Control and Prevention (CDC), has awarded new funding for the World Trade Center (WTC) Health Program Clinical Center of Excellence at the Icahn School of Medicine’s Department of Environmental Medicine and Public Health.

Under this new contract, which will fund up to $340 million over eight years, our WTC Health Program will continue to provide— at no cost—medical monitoring, treatment, and case management services for responders who participated in the rescue, recovery, debris clean-up, and related support services following the terrorist attacks on September 11, 2001. Our WTC Health Program, a component of the Mount Sinai Selikoff Centers for Occupational Health, is the largest such center in the country and proudly cares for more than 25,000 responders at its Manhattan, Staten Island, Suffern, and Yonkers, New York, locations.

“The ongoing support of the federal government ensures that we’re able to provide critically needed services to responders,” said Michael Crane, MD, MPH, Medical Director of the Selikoff Centers. “Decades after 9/11, we’re only beginning to understand the health effects related to exposure to the WTC disaster site. Thousands of responders have developed chronic physical and mental health conditions, and all of them require monitoring and dedicated, ongoing care. The terms of this contract underscore our WTC Health Program’s commitment to meet the expanding health care needs of our aging responder population, in areas including mental health, cancer care, and case management.”

Sandra M. Lowe, MD, Medical Director of the WTC Center’s Mental Health Program, added, “Many responders who developed psychiatric conditions due to their work at the WTC disaster site continue to experience symptoms, adding to their overall health burden. This funding will allow us to continue to address the growing mental health care needs of our program’s brave responders.”

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools,” aligned with a U.S. News & World Report “Honor Roll” Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York City and in the top five globally, and Mount Sinai Morningside in the top 30 globally; Newsweek also ranks The Mount Sinai Hospital highly in 11 specialties in “World’s Best Specialized Hospitals,” and in “America’s Best Physical Rehabilitation Centers.” For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter, and YouTube.

Share article on social media or email:

Prevent Blindness Declares Third Annual Thyroid Eye Disease (TED) Awareness Week as Nov. 14-20, 2022


Prevent Blindness declares Third Annual Thyroid Eye Disease Awareness Week, Nov. 14-20, 2022, offering free educational materials in English and Spanish.

Prevent Blindness, the nation’s leading nonprofit eye health and safety organization, has declared Nov. 14-20, 2022, as its third annual “Thyroid Eye Disease Awareness (TED) Week.” TED, sometimes called Graves’ ophthalmopathy or Graves’ Eye Disease, is an autoimmune disease in which the immune system causes inflammation and swelling and stimulates the production of muscle tissue and fat behind the eye.

To help raise awareness and provide free educational content to patients, care partners and healthcare professionals, Prevent Blindness offers TED fact sheets and social media graphics in English and Spanish, and a dedicated webpage. Also available is the “Thyroid Eye Disease” episode of the Focus on Eye Health Expert Series, featuring Prevent Blindness President and CEO Jeff Todd interviewing Sara Wester, MD, FACS, professor of clinical ophthalmology at Bascom Palmer Eye Institute, and TED patient Stephen Bander. TED Awareness Week is supported by Horizon Therapeutics, a global biotechnology company focused on rare, autoimmune and severe inflammatory diseases.

Risk factors for TED include:

  • Graves’ disease
  • Low levels of thyroid hormones (hypothyroidism)
  • Age: Usually affects middle-age adults but can occur at any age
  • Gender: Females are affected more than males
  • Family history of thyroid eye disease
  • Smoking: Smoking increases the risk of thyroid eye disease by 7–8 times, causes thyroid eye disease to have a longer “active phase,” and reduces the effectiveness of treatments
  • Radioactive iodine therapy: Radioactive iodine has been used to treat hyperthyroidism and Graves’ disease. This treatment should be used with caution in people with active thyroid eye disease as it may worsen the condition unless steroids are given at the same time
  • Low blood levels of selenium, a dietary mineral.


TED may cause eye pain, double vision, loss of vision, and changes to physical appearance which may negatively impact quality of life. Some TED patients experience depression, anxiety, loss of independence, and reduced self-confidence.

To help address this, the no-cost “Prevent Blindness Art Therapy Program” for people with TED and their care partners, now in its second session, provides participants with the opportunity to create art using a variety of artistic media to express thoughts and feelings. Participants also interact with registered art therapists who tailor the program topics, themes and materials for people affected by TED. Benefits of the Art Therapy program include:

  • Art therapy has been shown to help people improve their mental, emotional, and even physical wellness.
  • The process of creating art in a group setting can help reduce anxiety and depression, provide a way to express difficult emotions in a creative manner, and reduce isolation, which could be particularly important for people experiencing the challenging symptoms of TED.
  • The opportunity to help people build new connections, help themselves, and help others by sharing stories and experiences.

Those interested in participating in the next session may sign up for the Prevent Blindness Art Therapy Program waiting list. This program is supported by funding from Horizon Therapeutics.

“By providing TED patients and their care partners with information and tools they need to understand Thyroid Eye Disease, along with offering the Prevent Blindness Art Therapy Program to help address the mental health impact, we can help to minimize the negative effect that TED often has,” said Jeff Todd, president and CEO of Prevent Blindness.

For more information on TED, please visit https://preventblindness.org/thyroid-eye-disease/ or FOCUSonTED.com. For details on the Prevent Blindness Art Therapy program, visit https://preventblindness.org/events/art-therapy-fall-2022/.

About Prevent Blindness

Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at preventblindness.org, and follow us on Facebook, Twitter, Instagram, LinkedIn and YouTube.

###

Share article on social media or email:

New State of Disaster Philanthropy report finds Covid-19 giving shattered records, but only a fraction went to climate-related and humanitarian crises in 2020


Measuring the State of Disaster Philanthropy report cover

“All donors are disaster funders,” said Regine Webster, vice president at CDP. “At some point, that geography, that issue, or that population you care about is going to be affected by a disaster event.”

Foundation, corporate, government, and individual donors gave at unprecedented levels in 2020. A new report by Candid and the Center for Disaster Philanthropy (CDP) found nearly $121 billion in giving primarily in response to the COVID-19 pandemic. A fraction went toward other record-breaking climate-related disasters and humanitarian emergencies.

This year’s Measuring the State of Disaster Philanthropy 2022: Data to Drive Decisions report underscores philanthropy’s vital role in ensuring that disaster survivors and their communities have access to immediate relief and resources to rebuild and thrive.

Communities of color, women and girls, older adults, individuals with disabilities, LGBTQIA+ people, and other populations made vulnerable by systemic inequities are disproportionately affected by natural hazards. These communities need support to plan for, prevent, and mitigate the impact of future disasters.

The report calls on donors to give more and in ways that ensure vital resources go where they are needed most.

Key findings

As expected, COVID-19 overshadowed other disasters among donors. Of the $5.2 billion in disaster giving by institutional philanthropy, 96% went toward COVID-19, while the rest was in response to the most active Atlantic hurricane season on record; destructive earthquakes in Puerto Rico; devastating wildfires in the Amazon, Australia, and the U.S.; flooding across Asia; the humanitarian crisis in Yemen; and other disasters.

Other key findings include:

  • When comparing the year-to-year giving of 222 U.S. foundations, disaster-related funding in 2020 was nearly 19 times more than in 2019 (at $2.1 billion and $110.7 million, respectively). The enormous increase in funding in 2020 was due to the COVID-19 pandemic.
  • In 2020, $5.2 billion of funding to date came from foundations and public charities. Of this amount, 96% went toward COVID-19, while the remainder supported wildfires, storms, and general disaster efforts.
  • Candid’s analysis of corporate public announcements found $3.6 billion in disaster-related funding from corporate giving programs.
  • The Organisation for Economic Co-operation and Development’s Development Assistance Committee (DAC) distributed $36.4 billion for disasters and humanitarian crises in 2020. Non-DAC government donors and multilateral organizations contributed an additional $3.1 billion.
  • The Federal Emergency Management Agency (FEMA) distributed $57.6 billion for U.S. disasters in 2020, a $54 billion increase from 2019. The U.S. Department of Housing and Urban Development (HUD) allocated $9 billion in recovery efforts in 2020, an $8 billion increase from 2019. In 2020, the U.S. Economic Development Administration (EDA) invested approximately $1.2 billion in 988 projects, an $851.8 million increase from 2019.

“Disaster philanthropy from foundations and public charities looked different in 2020, due to COVID-19,” said Grace Sato, Candid’s research director. “Far more dollars and grants were awarded than usual to address the impacts of the pandemic. Otherwise, disaster-related funding was largely unchanged compared to prior years.”

As in previous years, most institutional philanthropic giving went toward response and relief efforts, while only a fraction supported risk reduction, mitigation, preparedness, reconstruction, and recovery.

A call to action

As natural hazards and extreme weather events continue to grow and become more dangerous due in large part to climate change, their negative impact on communities increases exponentially. Under-resourced and underserved populations are especially vulnerable because of systemic inequities.

“All donors are disaster funders,” said Regine Webster, vice president at CDP. “It fundamentally does not matter what your funding focus is. At some point, that geography, that issue, or that population you care about is going to be affected by a disaster event.”

The report asks donors to consider disasters in their giving, especially efforts to address climate change. It highlights the following equity-centered practices to maximize donors’ impact:

  • Address root causes.
  • Prioritize local organizations.
  • Provide unrestricted multi-year funding.
  • Don’t forget to support preparedness, mitigation, and recovery.

The report also notes the need for grantmakers to share their giving data with Candid for a more accurate picture of giving trends.

Measuring the State of Disaster Philanthropy 2022: Data to Drive Decisions is available at doi.org/10/gq4k9v.

About Candid

Candid is a 501(c)(3) nonprofit organization that provides the most comprehensive data and insights about the social sector. Every year, millions of nonprofits spend trillions of dollars around the world. Candid finds out where that money comes from, where it goes, and why it matters. Candid was formed in 2019 when GuideStar and Foundation Center merged. Candid combined GuideStar’s tools on nonprofits and Foundation Center’s tools on foundations with new resources to offer more comprehensive, real-time information about the social sector. Find out more at candid.org and @CandidDotOrg on Twitter, LinkedIn, and Instagram.

About the Center for Disaster Philanthropy

The Center for Disaster Philanthropy leverages the power of philanthropy to mobilize a full range of resources that strengthen communities’ ability to withstand disasters and recover equitably when they occur. It provides expert advice and resources while managing domestic and international disaster funds on behalf of corporations, foundations and individuals through targeted, holistic and localized grantmaking. Find out more at disasterphilanthropy.org, Twitter, and LinkedIn.

Share article on social media or email:



The Top 25 Healthcare Technology Leaders of Los Angeles for 2022


The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of Los Angeles for 2022. Over the past few years, Los Angeles has enjoyed a rise in prominence in the healthcare technology industry. It is increasingly the home of new startups, and in October 2021, the 20,000 square foot office of BioscienceLA opened in Culver City to serve as a “headquarters” for the many bioscience startups, entrepreneurs, and researchers scattered across Los Angeles County. Meanwhile, the exceptional leaders on this year’s list and the companies they represent show that Los Angeles already has an incredibly dynamic, innovative healthcare technology industry.

Some of the distinguished leaders on this year’s list include John Beaver, President and CEO of BIOLASE, whose laser dental systems provide clinically superior results for many types of common dental procedures, restoring and repairing dental anatomy, alleviating pain, and reducing fear and anxiety in patients. CEO Mark McDonough’s PierianDx is enabling clinicians and medical facilities to advance clinical genomics programs and modernize patient care by curating the world’s genetic knowledge and providing sophisticated analysis tools to its customers. And CEO John Kilcoyne’s JenaValve Technology is developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of both severe aortic regurgitation and stenosis.

This year’s honorees and the companies they lead are helping to put Los Angeles on the healthcare technology map, which has for so long been dominated by cities like Boston and New York City, with their revolutionary solutions to healthcare’s biggest problems. In specialties as wide-ranging as dentistry, plastic surgery, lung imaging, and cardiovascular disease, among many others, these leaders are guiding their companies to success and bettering patient outcomes across the healthcare industry. Please join us in celebrating The Top 25 Healthcare Technology Leaders of Los Angeles for 2022.

Joe Kiani (Masimo), John Rush (North American Scientific), John Beaver (BIOLASE, Inc.), Matt Thompson (Endologix), Mark McDonough (PierianDx), Johnson Lau (Athenex), Bassil Dahiyat (Xencor), Todd Zavodnick (Dermavant Sciences), Ron Menezes (Sientra, Inc.), John Kilcoyne (JenaValve Technology, Inc.), Jason Kirkness (4DMedical), Mark Herrema (Newlight Technologies), Carl St. Bernard (CeloNova BioSciences, Inc.), Brian Lee (PBS Biotech, Inc.), Chris Sharp (Skye Biologics, Inc.), Matthew Haller (RxSight, Inc.), Ming-Chou Lee (Exagen Inc.), Willis Lee (Emmaus Life Sciences, Inc.), Venkat Yepuri (ImmPACT BIO), Marinela Gombosev (SPARK Neuro), Deanna Harshbarger (Cala Health), Jeff Dunklin (Lucence), Nitin Arneja (Beta Bionics), Tariq Salim (Provivi, Inc.), Nadia Agopyan (Marker Therapeutics, Inc.)

The full article can be read at https://thehealthcaretechnologyreport.com/

About The Healthcare Technology Report

The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on healthcare technology and the various companies, executives, and investors that make up the sector.

Share article on social media or email:

Darena Solutions announces partnership with IntrinsiQ Specialty Solutions to meet Cures Act requirements


IQSS is excited to partner with Darena Solutions to implement MeldRx™ for our UroChartEHR® solution to help ensure Cures Act compliance by utilizing FHIR® APIs for streamlining connectivity for our specialty provider customers. – ROBERT NEFF, VP DIGITAL HEALTH SOLUTIONS, IQSS

Darena Solutions today announced its collaboration with IntrinsiQ Specialty Solutions (IQSS), a part of AmerisourceBergen, to help providers meet Cures Act requirements by giving patients access, on request, to their health information. Through the partnership, Darena Solutions will integrate its MeldRx™, a bi-directional data exchange, with IQSS’ urology-specific UroChartEHR® platform, giving IQSS’ customers the ability to share data with their patients securely, other providers, payers, Health Information Exchanges, and Registries at the point of care.

Darena Solutions became the first organization in the nation to be certified by the Office of National Coordinator of Health IT (ONC) for enabling FHIR® Application Programming Interface (APIs) as part of the Cures Act requirements. The partnership with IQSS furthers Darena’s vision of improving healthcare interoperability with better outcomes for both the providers and the patients. MeldRx™ will empower providers using IQSS’ UroChartEHR® to deliver patient-centered specialty care in Urology, Orthopedics, Vision, and Infusion.

“IQSS is excited to partner with Darena Solutions to implement MeldRx for our UroChartEHR® solution to help ensure Cures Act compliance by utilizing FHIR® APIs for streamlining connectivity for our specialty provider customers,” said Robert Neff, Vice President of Digital Health Solutions at IntrinsiQ Specialty Solutions.

“Achieving Cures Act compliance is merely the first step to healthcare interoperability,” says Satish Subramani, Executive VP and Partner of Darena Solutions. “IQSS and Darena Solutions share a common goal of enhancing the quality of patient care. By integrating with MeldRx™, IQSS will enable bi-directional data exchange between providers and patients in an easy and secure manner. Access to provider-validated data from patients can be a game-changer for physician practices.”

MeldRx™ is a comprehensive Ecosystem developed by Darena Solutions for EHRs and Providers. This Ecosystem includes the ONC Certified FHIR® API that allows EHRs to meet all the certification mandates and future-proofs them from evolving regulatory and interoperability requirements. The ecosystem relieves practitioners from the burdens of integration, interpreting regulations, finding solutions, and staff disruption.

ABOUT AMERISOURCEBERGEN

AmerisourceBergen fosters a positive impact on the health of people and communities around the world by advancing the development and delivery of pharmaceuticals and healthcare products. As a leading global healthcare company, with a foundation in pharmaceutical distribution and solutions for manufacturers, pharmacies, and providers, we create unparalleled access, efficiency, and reliability for human and animal health. Our 42,000 global team members power our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500 with more than $200 billion in annual revenue. Learn more at https://amerisourcebergen.com/.

ABOUT DARENA SOLUTIONS

Darena Solutions delivers an Ecosystem of FHIR® enabled interoperability, regulatory compliance, and analytics solutions to EHRs, providers, and payers. By creating channels for data sharing between providers, payers, and patients, Darena enables healthcare organizations to achieve compliance and derive insights for prospective decision-making resulting in better patient outcomes. Learn more at http://www.darenasolutions.com You can connect with us on LinkedIn and Twitter.

Share article on social media or email:



Supporting Antimicrobial Stewardship Using Point of Care CRP Testing, Upcoming Webinar Hosted by Xtalks


Tackling AMR requires a multi-faceted approach and research has shown how incorporating CRP (C-reactive protein) testing into clinical practice may help to limit antibiotic use to only those patients with severe bacterial infections and thereby support antimicrobial stewardship.

The World Antimicrobial Awareness Week, held from November 18 to 24, 2022, calls attention to the high priority global issue¹,² of antimicrobial resistance (AMR). We know that 80% of acute respiratory tract infections in general practice are caused by viral infection where the use of antibiotics is of little to no benefit³. There is a direct relationship between the prescribing of antimicrobials and the development of AMR4, making infections harder to treat and increasing the risk of disease spread, severe illness and death⁴. Tackling AMR requires a multi-faceted approach and research has shown how incorporating CRP (C-reactive protein) testing into clinical practice may help to limit antibiotic use to only those patients with severe bacterial infections and thereby support antimicrobial stewardship.

In this webinar, featured speaker Dr. Rogier Hopstaken, a GP from the Netherlands whose work and research drove the implementation of CRP point of care testing (POCT) in the country, will discuss how implementing CRP testing at the point of care has the potential to curb the problem of AMR and help change antibiotic prescribing behaviours in primary care settings. Rogier will review international experiences, barriers to implementation and provide recommendations for next steps. Together with David Barber, Advanced Practitioner LHCH Knowsley Community Respiratory Service, and featured speakers from LumiraDx, Medical Director Matt Fay, and Associate Director in Medical Affairs Lucy Lehane, they will review case studies and explore the value of portable CRP testing with patients in community settings using the LumiraDx Platform technology at the point of care.

Register for this webinar to learn about supporting antimicrobial stewardship using point of care CRP testing and changing antibiotic prescribing behaviours in primary care settings.

Join Dr. Rogier Hopstaken, MD, PhD, Star-shl Diagnostic Centres, Etten-Leur, Netherlands; Dr. Matthew Fay, GP Principal, Willows Medical Practice, Bradford; Lucy Lehane, Associate Director Medical Affairs, LumiraDx; and David Barber, Advanced Practitioner, LHCH Knowsley Community Respiratory Service, for the live webinar on Tuesday, November 22, 2022, at 8am EST (2pm CET/EU-Central).

For more information, or to register for this event, visit Supporting Antimicrobial Stewardship Using Point of Care CRP Testing.

References:

1. World Health Organisation (WHO). Global action plan on antimicrobial resistance, 2015.

2. O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. London: HM Government and Wellcome Trust, 2016.

3. Goossens H, Ferech M, Vander Stichele R, et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet, 2005;365:579–87.

4. World Health Organisation (WHO). Antimicrobial Resistance Factsheet, November 2021.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

BrightStar Care® Nationally Honored Its Nurses and Caregivers For Providing Unparalleled Care and its Franchisees for Their Outstanding Achievements in 2022


News Image

BrightStar Care, the leading nationwide home care and medical staffing franchise known for providing the highest standard of quality home care, celebrated milestones and commemorated achievements at its 2022 Annual Conference. The conference was held in Henderson, Nevada at the M Resort from October 25-27 and featured content-rich sessions, presentations, and more. BrightStar Care also honored the winners of its annual Nurse of the Year and Caregiver of the Year awards and its Franchisee of the Year and Rookie of the Year.

This year’s Nurse and Caregiver of the Year award presentation came as a heartwarming surprise, as BrightStar Care CEO and Founder Shelly Sun recognized all eight regional honorees as national winners, granting each recipient a $5,000 reward. BrightStar Care’s nurses and caregivers are the heart and soul of the company, and it is extremely important to the organization to dedicate time each year to honor and celebrate them. In August 2022, BrightStar Care recognized four nurses and four caregivers as regional Nurses and Caregivers of the Year. Now all eight honorees are national winners.

Nurse of the Year national honorees include:

· West Region Winner: Jayne Maher of BrightStar Care Bedford/Manchester, New Hampshire

· Northeast Region Winner: Janet Howell, BSN, RN of BrightStar Care Honolulu, Hawaii

· Southeast Region Winner: Carmen Streete, HHA of BrightStar Care S. Charlotte, North Carolina

· Midwest Region Winner: Bridgete Biggs, CNA of BrightStar Care Naperville, Illinois

Caregiver of the Year national honorees include:

· West Region Winner: Ubong-Abasi James Edemenang, CNA of BrightStar Care Salt Lake City, Utah

· Northeast Region Winner: Linda Santos, RN of BrightStar Care Stroudsburg, Pennsylvania

· Southeast Region Winner: Kandi Peterson, RN of BrightStar Care S. Charlotte, North Carolina

· Midwest Region Winner: Julie Govier, LPN of BrightStar Care Overland Park, Kansas

In addition, BrightStar Care also recognized 70 franchise owner groups across 19 different award titles for their clinical excellence, commitment to their clients, financial growth, expansion within their territories, and their contributions to the brand’s continued success.

Among the winners were:

· Franchisee of the Year: Chris Miller, Owner and President of BrightStar Care of East Lansing was recognized for his excellent work advocating to preserve home care services in the state of Michigan following the challenging no-fault auto law that went into effect in 2021.

· Rookie of the Year: Giselle and David Bardwell, owners of BrightStar Care of Cuyahoga West, were awarded for their tremendous financial achievements as new owners over the past year.

“BrightStar Care would not be where it is today, celebrating 20 years, without the outstanding work of our best and brightest, this includes our incredible nurses, caregivers, and franchisees,” said Shelly Sun, CEO and Founder of BrightStar Care. “These awards highlight the interconnectedness between our nurses, caregivers, and franchise owners as they work together to deliver the highest standard of care to thousands of moms, dads, grandmas, and grandpas. I wholeheartedly believe that each of our regional nurse and caregiver winners deserved national recognition as the care they deliver has made a lasting impression on the lives of our clients and the entire BrightStar Care network.”

The eight nurses and caregivers who were recognized were nominated by BrightStar Care clients, family members of clients, and/or BrightStar Care employees. The Franchise of the Year and Rookie of the Year winners were nominated and chosen by BrightStar Care’s Franchise Support Center team. When selecting these winners, BrightStar Care examined significant milestones reached by owners across its franchise network, their impact on the industry and their communities, and their financial achievements over the past year.

In addition to the awards announced at the conference, BrightStar Care also recognized owners Lisa Marie Swiatkowski and Jim Boone of BrightStar Care Venice and Port Charlotte, Florida for their outstanding leadership in guiding their team through the challenges of Hurricane Ian. Swiatkowski and Boone’s locations in Florida were severely impacted by the hurricane yet their nurses, caregivers and administrative teams sprang into action to ensure high-risk clients were attended to and safe, despite their own loss of personal property and personal hardships from the hurricane.

Following the events of Hurricane Ian, BrightStar Care locations across the country created a GoFundMe fundraiser to support Swiatkowski and Boone’s locations. In total, the GoFundMe accounts raised $55,000. This fundraiser showcased how the BrightStar Care network came together to financially support their team members in need. BrightStar Franchising contributed the initial $10,000 to start the GoFundMe and additionally granted the BrightStar Care Venice and Port Charlotte locations a donation of $26,000 to specific caregivers, nurses and office staff directly impacted by the hurricane in addition to scrubs, PPE and other essential items to keep the agencies operating and safe.

For more information about BrightStar Care’s nursing and caregiving opportunities or information on care services, please visit http://www.brightstarcare.com. For information on BrightStar Care franchising opportunities, please visit http://www.brightstarfranchising.com.

About BrightStar Care:

Founded in 2002, BrightStar Care is a national home care agency with more than 365 franchised locations nationwide that provide medical and non-medical in-home care services to clients in their homes and supplemental care staff to businesses. BrightStar Care franchise agencies across the country employ over 15,000 caregivers and 5,700 registered nurses who oversee the care and safety of each individual client. BrightStar Care offers custom medical staffing solutions to corporate entities and holds national accounts with government agencies across distinct patient populations providing healthcare staff anywhere care is needed. Female founded and led by CEO Shelly Sun, BrightStar Care is committed to providing a higher standard of care through its clinical nurse-led care model. As a member of Moving Health Home, BrightStar Care also actively advocates to change federal and state policies that prevent the home from being an accredited clinical care site. More than 95% of BrightStar Care agencies are Joint Commission accredited – the gold standard within the health care industry. BrightStar Care has also been the only national home care franchise to consecutively receive The Joint Commission’s Enterprise Champion for Quality award for the past decade.

Share article on social media or email:

Innovation Fertility Announces Acquisition of RMA of Michigan


RMA of Michigan, a Michigan-based, regional leader in advanced fertility care, and Innovation Fertility, a network of leading IVF clinics and laboratories, today announced that RMA of Michigan has been acquired by affiliates of Innovation Fertility. The financial terms of the transaction were not disclosed. RMA of Michigan is led by founders Brad T. Miller, M.D., FACOG, and Lynda Wolf, M.D., FACOG.

Reproductive endocrinology is among the fastest-growing medical specialties in the country. Demand for advanced fertility care will continue to rise as couples are deciding to have children later in life and the prevalence of male infertility, driven by environmental and lifestyle factors, increases. Further trends favoring industry demand are a growing percentage of same-sex couples desiring children and an increasing number of employers offering benefits for IVF and genetic testing services.

“We welcome Dr. Brad Miller, Dr. Lynda Wolf, and the entire RMA of Michigan team to the Innovation Fertility family. The acquisition brings together two organizations with an unwavering commitment to patient experience and outcomes,” said Dwight P. Ryan, CEO of Innovation Fertility.

“The mission of RMA of Michigan has always been to provide personalized fertility care with the highest chances of success. We are thrilled to partner with Innovation Fertility and are excited about the operating capabilities and capital resources they provide to complement the strength of our exceptional clinical team,” said Dr. Miller.

“RMA of Michigan’s mission has always been to provide patient-driven care,” said Dr. Wolf. “Partnering with Innovative Fertility provides me the support I need so that I can focus on my patients.”

RMA of Michigan’s commitment to providing a first-class patient experience remains unchanged, and management expects that under the leadership of Innovation Fertility, they will have the flexibility and expertise to focus on what matters most – helping patients build their families.

ABOUT RMA OF MICHIGAN

Based in Detroit, MI, RMA of Michigan is one of the leading fertility clinics in the Midwest. Founded in 2006 by Drs. Miller and Wolf, the Company’s physicians complete around 800 IVF cycles each year.

For more information, visit: http://www.rmami.com

ABOUT INNOVATION FERTILITY

Innovation Fertility provides patients with innovative, cutting-edge fertility treatment options to meet their unique family planning goals. As a team, they combine premier reproductive endocrinologists with laboratory operations, resulting in exceptional medical care and an unparalleled patient experience.

FORWARD-LOOKING STATEMENT

This communication expressly or implicitly contains certain forward-looking statements that involve risks and uncertainties, including statements regarding expectations for RMA of Michigan following its acquisition by Innovation Fertility. If any of these risks or uncertainties materialize, or if any of RMA of Michigan’s or Innovation Fertility’s assumptions prove incorrect, RMA of Michigan’s results could differ materially from the results expressed or implied by these forward-looking statements. All forward-looking statements in this communication are based on information available to RMA of Michigan and Innovation Fertility as of the date of this communication, and RMA of Michigan and Innovation Fertility do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

Share article on social media or email: